Literature DB >> 27885314

In Pursuit of Optimal Cytoreduction in Ovarian Cancer Patients: The Role of Surgery and Surgeon.

Lele Shashikant1, P Kesterson Joshua2.   

Abstract

The standard of care for women with advanced stage epithelial ovarian cancer (EOC) involves surgery followed by adjuvant platinum-based combination chemotherapy. One of the goals of surgery is to resect all macroscopic disease. In this review we will discuss the justification for an aggressive surgical approach, including a discussion of factors limiting its implementation and suggestions for providing appropriate surgical intervention for all women with EOC.

Entities:  

Keywords:  cytoreduction; epithelial ovarian cancer; optimal; surgery

Year:  2009        PMID： 27885314      PMCID： PMC5118819     

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


  44 in total

1.  Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population-based survival analysis in Finland.

Authors:  Salla Kumpulainen; Seija Grénman; Pentti Kyyrönen; Eero Pukkala; Risto Sankila
Journal:  Int J Cancer       Date:  2002-12-10       Impact factor: 7.396

Review 2.  The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review.

Authors:  Flora Vernooij; Peter Heintz; Els Witteveen; Yolanda van der Graaf
Journal:  Gynecol Oncol       Date:  2007-04-12       Impact factor: 5.482

3.  The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

Authors:  Dominik Wolf; Anna M Wolf; Holger Rumpold; Heidi Fiegl; Alain G Zeimet; Elisabeth Muller-Holzner; Martina Deibl; Guenther Gastl; Eberhard Gunsilius; Christian Marth
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

4.  Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.

Authors:  Mirjam J A Engelen; Henrike E Kos; Pax H B Willemse; Jan G Aalders; Elisabeth G E de Vries; Michael Schaapveld; Renee Otter; Ate G J van der Zee
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

Review 5.  Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

6.  Secretion of vascular endothelial growth factor in ovarian cancer.

Authors:  A D Santin; P L Hermonat; A Ravaggi; M J Cannon; S Pecorelli; G P Parham
Journal:  Eur J Gynaecol Oncol       Date:  1999       Impact factor: 0.196

7.  Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.

Authors:  Deborah Schrag; Craig Earle; Feng Xu; Katherine S Panageas; K Robin Yabroff; Robert E Bristow; Edward L Trimble; Joan L Warren
Journal:  J Natl Cancer Inst       Date:  2006-02-01       Impact factor: 13.506

8.  The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma.

Authors:  H M Goodman; B L Harlow; E E Sheets; M G Muto; S Brooks; M Steller; R C Knapp; R S Berkowitz
Journal:  Gynecol Oncol       Date:  1992-09       Impact factor: 5.482

9.  Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

Authors:  Dennis S Chi; Corinna C Franklin; Douglas A Levine; Faina Akselrod; Paul Sabbatini; William R Jarnagin; Ronald DeMatteo; Elizabeth A Poynor; Nadeem R Abu-Rustum; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482

10.  Predictors of comprehensive surgical treatment in patients with ovarian cancer.

Authors:  Barbara A Goff; Barbara J Matthews; Eric H Larson; C Holly A Andrilla; Michelle Wynn; Denise M Lishner; Laura-Mae Baldwin
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860
View more
  2 in total

1.  Diaphragmatic Peritonectomy and Full-Thickness Resection in CRS/HIPEC May Allow Higher Completeness of Cytoreduction Rates with a Low Rate of Respiratory Complications.

Authors:  Andrea Craus-Miguel; Juan José Segura-Sampedro; Xavier González-Argenté; Rafael Morales-Soriano
Journal:  Ann Surg Oncol       Date:  2021-01-06       Impact factor: 5.344

2.  Higher Level of Fatty Acid Synthase Enzyme Predicts Lower Rate of Completing Debulking Surgery in Epithelial Ovarian Cancer.

Authors:  Gatot Nyarumenteng Adhipurnawan Winarno; Yudi Hidayat; Setiawan Soetopo; Sofie Rifayani Krisnadi; Maringan Diapari Lumban Tobing; Syahrul Rauf
Journal:  Asian Pac J Cancer Prev       Date:  2020-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.